首页> 外文期刊>International journal of laboratory hematology >Performance evaluation of the micro INR INR ? ? point‐of‐care INR INR ‐testing system
【24h】

Performance evaluation of the micro INR INR ? ? point‐of‐care INR INR ‐testing system

机译:Micro InR INR的性能评估? 还 护理点INR INR -TESTING系统

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Introduction Point‐of‐care International Normalised Ratio ( INR ) testing is used frequently. We evaluated the micro INR ? POC system for accuracy, precision and measurement repeatability, and investigated instrument and test chip variability and error rates. Methods Venous blood INR s of 210 patients on warfarin were obtained with Thromborel ? S on the Sysmex CS ‐2100i ? analyser and compared with capillary blood micro INR ? values. Precision was assessed using control materials. Measurement repeatability was calculated on 51 duplicate finger‐prick INR s. Triplicate finger‐prick INR s using three different instruments (30 patients) and three different test chip lots (29 patients) were used to evaluate instrument and test chip variability. Results Linear regression analysis of micro INR ? and Sysmex CS 2100i ? values showed a correlation coefficient of 0.96 ( P ??.0001) and a positive proportional bias of 4.4%. Dosage concordance was 93.8% and clinical agreement 95.7%. All acceptance criteria based on ISO standard 17593:2007 system accuracy requirements were met. Control material coefficients of variation ( CV ) varied from 6.2% to 16.7%. The capillary blood measurement repeatability CV was 7.5%. No significant instrument ( P ?=?.93) or test chip ( P ?=?.81) variability was found, and the error rate was low (2.8%). Conclusion The micro INR ? instrument is accurate and precise for monitoring warfarin therapy.
机译:摘要介绍护理点频繁使用的国际标准化比率(INR)测试。我们评估了Micro Inr吗? PoC系统的精度,精度和测量可重复性,以及调查的仪器和测试芯片变异性和误差率。方法用Thromborel获得210例Warfarin患者的静脉血液吗? s在sysmex cs -2100i上?分析仪与毛细血管血微INR进行比较吗?价值观。使用对照材料评估精度。测量可重复性在51副本的手指刺入INR S计算中计算。使用三种不同仪器(30名患者)和三种不同的测试芯片批次(29名患者)的三份手指刺激INR用于评估仪器和测试芯片变化。结果微INR线性回归分析?和sysmex cs 2100i?值显示相关系数为0.96(p≤000001),阳性比例偏差为4.4%。剂量一致性为93.8%,临床协议95.7%。基于ISO标准的所有验收标准满足了系统精度要求。变异的控制材料系数(CV)的变异系数从6.2%变化至16.7%。毛细血管血液测量可重复性CV为7.5%。没有任何重要的仪器(p?=Δ.93)或测试芯片(p?=Δ.81)可变性,误差率低(2.8%)。结论微型INR?仪器准确,精确地监测华法林治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号